| Document |
Document Title |
|
WO/2009/095615 |
The subject matter of the invention is the use of at least one active ingredient derived from Cyperus esculentus in or for the preparation of a cosmetic and/or dermopharmaceutical composition for combating skin ageing, preferably by acti...
|
|
WO/2009/096905 |
There is presently provided methods for delivering an anti-fibrotic or anti-cancer agent to a cell. The methods comprise contacting a cell with an effective amount of imidazolium and imidazolinium compounds as described herein, including...
|
|
WO/2009/096579 |
Disclosed is a nutritional composition for preventing hyperglycemia, which comprises a nitrogen source, a lipid and a sugar component, wherein the nitrogen source comprises free isoleucine and/or free leucine, the lipid comprises a middl...
|
|
WO/2009/092323 |
Provided are uses of PDCD5 polypeptide or polynucleotide encoding it for preparing tumor chemo-sensitizer and protecting normal or diseased tissues and organs from injury or further damage. Drug combinations comprising chemotherapeutic d...
|
|
WO/2009/087988 |
Provided is a composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy. The composition is a composition for reducing oxidative stress a...
|
|
WO/2009/084482 |
Disclosed is a means for promoting the absorption of a sesamin component in the body. The absorption of a sesamin component in the body can be promoted by using the sesamin component in combination with a quercetin glycoside.
|
|
WO/2009/084743 |
An external preparation containing an active hydrogen-generating agent which generates active hydrogen in the case of bringing a plural number of agents into contact with each other and/or an active hydrogen-generating agent which activa...
|
|
WO/2009/084612 |
Disclosed is a method for producing an eriocitrin-containing material, which comprises the steps of: extracting a citrus extract containing eriocitrin from a citrus fruit with an extraction solvent; and separating eriocitrin from the cit...
|
|
WO/2009/078366 |
Disclosed is a stable α-lipoic acid. Also disclosed is a method for producing α-lipoic acid nanoparticles, which comprises a step of preparing an aqueous dispersion liquid containing α-lipoic acid and a nonionic surfactant; a step of ...
|
|
WO/2009/078474 |
The present invention provides an agent for reducing a side effect of an anticancer drug, which comprises a thrombin-like enzyme.
|
|
WO/2009/075564 |
The present invention relates to a liquid nutritional composition for paediatric patients comprising beta -galacto -oligosaccharides, fructan, non -digestible alpha -glucan and hemicellulose.
|
|
WO/2009/076506 |
The present invention concerns the γ-glutamylcysteine treatment to reduce oxidative damage caused by ischemia/reperfusion events such as pulmonary hypertension, transplant, cardiac bypass and other surgeries, and trauma. In specific emb...
|
|
WO/2009/075573 |
The present invention relates to a liquid nutritional composition for paediatric patients comprising beta-galacto-oligosaccharides, fructan, non-digestible alpha-glucan and hemicellulose.
|
|
WO/2009/072004 |
The present invention relates to methods for decreasing cellular DNA repair in a target patient; decreasing cellular NAD+ biosynthesis in a target patient; increasing efficiency of radiation therapy in a target patient; modulating nicoti...
|
|
WO/2009/072004 |
The present invention relates to methods for decreasing cellular DNA repair in a target patient; decreasing cellular NAD+ biosynthesis in a target patient; increasing efficiency of radiation therapy in a target patient; modulating nicoti...
|
|
WO/2009/069736 |
Disclosed is a nitrogenated compound represented by the formula (I) [wherein A represents an aryl which may have a substituent or the like; B's independently represent a hydrogen atom, a halogen or the like; n represents an integer of no...
|
|
WO/2009/068798 |
The invention relates to a composition for protecting and/or preserving cells, tissues and organs, characterised in that it includes at least one modified positively-charged cyclodextrin preferably closely associated with an anti-oxidant...
|
|
WO/2009/064004 |
It has been required to develop a drink which contains citrulline, generates little offensive odor when stored or heated and is easy to drink. Thus, a drink containing citrulline together with citric acid, sodium citrate or disodium hydr...
|
|
WO/2009/055863 |
The present invention relates to desferoxamine conjugates, derivatives and analogues thereof. In particular, the present invention relates to desferoxamine conjugates, analogues and derivatives thereof, and methods for reducing levels of...
|
|
WO/2009/053637 |
The subject of the present invention is an anti-ricin antibody and the use thereof for the treatment of an individual suffering from ricin poisoning.
|
|
WO/2009/048120 |
A stable astaxanthin-containing composition which has neither an unpleasant taste nor an unpleasant odor and has a good flavor and improved solubility in aqueous liquids. Also provided is a composition having improved astaxanthin absorba...
|
|
WO/2009/048119 |
It is intended to provide a medicinal composition available as a substitute for FGF2 which contains, as the active ingredient, a chimeric protein comprising an amino acid sequence derived from the amino acid sequence of FGF1 protein by t...
|
|
WO/2009/047290 |
A method for the treatment or prevention of a cell or tissue damage in a living subject due to the exposure to ionizing radiation is provided, which comprises administration to said subject of a quaternary pyridinium salt of formula (I) ...
|
|
WO/2009/045655 |
This invention encompasses methods of preserving protein function by contacting a protein with a composition comprising one or more purine nucleosides (such as e.g., adenosine or uridine) and an antioxidant (such as e.g., manganese). In ...
|
|
WO/2009/043176 |
Herbal compositions and their use in the prevention and/or treatment of hepatitis are provided The herbal compositions comprise an extract of flowers, leaves, and roots from the plant genera Cordia, Annona, and Curcuma, respectively, whe...
|
|
WO/2009/043176 |
Herbal compositions and their use in the prevention and/or treatment of hepatitis are provided The herbal compositions comprise an extract of flowers, leaves, and roots from the plant genera Cordia, Annona, and Curcuma, respectively, whe...
|
|
WO/2009/045655 |
This invention encompasses methods of preserving protein function by contacting a protein with a composition comprising one or more purine nucleosides (such as e.g., adenosine or uridine) and an antioxidant (such as e.g., manganese). In ...
|
|
WO/2009/041714 |
To provide an external preparation for free radical diseases which is excellent in transdermal and transmucosal absorption properties. An external preparation is obtained by combining 3-methyl-1-phenyl-2-pyrazolin-5-one with a metabolic ...
|
|
WO/2009/041521 |
An extensive and intensive study was made on an NAD(P)H oxidase inhibitor. As a result, it was confirmed that a quinolone derivative having, at position-2, an alkyl group substituted by a hetero atom or the like had a good NAD(P)H oxidas...
|
|
WO/2009/041640 |
Disclosed is a plant extract which contains an o-diphenol-type chlorogenic acid component at a high concentration. Also disclosed is a plant extract which contains substantially no feruloyl quinic acid component or caffeine component, an...
|
|
WO/2009/036574 |
A method of using an estrogen receptor agonist and antagonist to reduce a toxic effect of a cytostatic drug on bone marrow derived cells in a biological system. The methods comprise contacting the cells with a therapeutically effective a...
|
|
WO/2009/036590 |
The present invention relates to novel compounds from Antrodia cinnamomea and their use.
|
|
WO/2009/027056 |
The present invention relates to novel heparin-nitroxide derivatives comprising heparin and at least two and more nitroxides/polynitroxide radicals that are covalently coupled to heparin by derivatisation of glycosaminoglycan carboxyl or...
|
|
WO/2009/027056 |
The present invention relates to novel heparin-nitroxide derivatives comprising heparin and at least two and more nitroxides/polynitroxide radicals that are covalently coupled to heparin by derivatisation of glycosaminoglycan carboxyl or...
|
|
WO/2009/028643 |
Disclosed are: a highly pure, inexpensive and safe composition having a high carotenoid content; a method for the industrial production of the composition; a functional food, a pharmaceutical composition or a cosmetic comprising the comp...
|
|
WO/2009/027056 |
The present invention relates to novel heparin-nitroxide derivatives comprising heparin and at least two and more nitroxides/polynitroxide radicals that are covalently coupled to heparin by derivatisation of glycosaminoglycan carboxyl or...
|
|
WO/2009/025315 |
Disclosed is a composition for increasing the amount of tetrahydrocurcumin, which is believed to be useful for the maintenance of good health or the amelioration of a disease condition, in a living body efficiently through oral intake. S...
|
|
WO/2009/024957 |
A method of treating or preventing organophosphate exposure associated damage in a subject in need thereof is provided. The method comprising providing the subject with a therapeutically effective amount of the acetylcholinesterase splic...
|
|
WO/2009/025326 |
Disclosed is a method for producing a hydroxytyrosol-containing aqueous olive extract, which comprises a clearing step of contacting an aqueous opaque component with diatomaceous earth, wherein the aqueous opaque component is selected fr...
|
|
WO/2009/023742 |
The present invention concerns surface display systems based on conjugates of heterologous molecules to externally exposed spore coat protein sequences. In particular, the invention concerns conjugates, such as fusion proteins, comprisin...
|
|
WO/2009/023742 |
The present invention concerns surface display systems based on conjugates of heterologous molecules to externally exposed spore coat protein sequences. In particular, the invention concerns conjugates, such as fusion proteins, comprisin...
|
|
WO/2009/023742 |
The present invention concerns surface display systems based on conjugates of heterologous molecules to externally exposed spore coat protein sequences. In particular, the invention concerns conjugates, such as fusion proteins, comprisin...
|
|
WO/2009/020192 |
It is intended to provide a composition for oral intake which can effectively prevent skin damage induced by the exposure to ultraviolet light when orally taken. This problem can be solved by a composition for oral intake for preventing ...
|
|
WO/2009/019260 |
The present invention provides compounds and methods for the treatment and prophylaxis of ischemia reperfusion injury. In particular the invention provides compounds which function to suppress Toll-like Receptor 2 biological function or ...
|
|
WO/2009/013596 |
The present invention relates to nutritional products containing hydroxytyrosol, particularly food products (i.e: fortified edible oils and fortified edible oil-containing products) and dietary supplements (i.e.: soft gel capsules contai...
|
|
WO/2009/014702 |
In one embodiment, the present invention relates to a method of treating a cancer characterized by inhibition of Fas-mediated apoptosis, comprising administering to a patient suffering from the cancer a pharmaceutically-effective amount ...
|
|
WO/2009/014702 |
In one embodiment, the present invention relates to a method of treating a cancer characterized by inhibition of Fas-mediated apoptosis, comprising administering to a patient suffering from the cancer a pharmaceutically-effective amount ...
|
|
WO/2009/006773 |
Disclosed is an optically active N- (α-mercaptopropionyl) glycine, that is R-N- (α-mercaptopropionyl) glycine or S-N- (α-mercaptopropionyl) glycine, its preparing method, a pharmaceutical prepn. containing the same compound or its med...
|
|
WO/2009/004842 |
It is intended to develop a technique whereby a vaccine for swine edema disease is produced at a low cost and a high efficiency. More specifically, swine edema disease toxic protein (Stx2e protein) gene is expressed in a plant cell at a ...
|
|
WO/2009/001322 |
The inventors have studied the kinetic and hierarchy of activation of apoptogenic caspases during myocardial ischemia and have found that caspase 2 plays a major role during the cardiac pathology by a very fast activation after an ischem...
|
